2JK-12409-55383
3 vaccinations
2 coded responses
13 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 532 / WI
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Registered in v-safe
- 2020-12-30
- 2021-01-05
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-15
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-21
- 2021-01-27
-
2021-02-10
Survey response — day 28, dose 2MedDRA: Hospitalisation — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Hospitalized for HGMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Report sent to call center — day 28, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-17
- 2021-02-22
- 2021-04-26
-
2021-08-19
Dose 3 — Pfizer-BioNTech
- 2022-01-11
-
2022-02-19
Survey response — 6 months, dose 3MedDRA: Delivery — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Delivered a babyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-19
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2022-02-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-08-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-17 | Unsuccessful | |
| 2021-02-10 | Unsuccessful | |
| 2022-02-19 | Unsuccessful |
Free text
Release 4 — day 28, dose 2
Symptoms: Hospitalized for HG
Release 11 — 6 months, dose 3
Symptoms: Delivered a baby
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Hospitalisation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release